Patent ID: 11875899
Assignee: VERINATA HEALTH, INC.
Field: Biotechnology (Chemistry)
Classification: CPC G  A  C | IPC C  G

Claim 16:
17. A method of monitoring a treatment of a subject for a cancer, said method comprising:
performing the method according to claim 1 on a sample from said subject or receiving results of such a method performed on said sample before or during said treatment to obtain a first measurement of the sequence of interest; and
performing the method according to claim 1 on a second sample from said subject or receiving the results of such a method performed on said second sample at a later time during or after said treatment to obtain a second measurement of the sequence of interest; where a reduced number or severity of aneuploidy in said second measurement is an indicator of a positive course of treatment and the same or increased number or severity of aneuploidy in said second measurement is an indicator of a negative course of treatment and when said indicator is negative adjusting said treatment to a more aggressive treatment regimen or a palliative treatment regimen.